SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-14-037802
Filing Date
2014-02-06
Accepted
2014-02-06 06:15:18
Documents
12

Document Format Files

Seq Description Document Type Size
1 424B4 d513724d424b4.htm 424B4 3035304
2 GRAPHIC g513724g21v79.jpg GRAPHIC 56346
3 GRAPHIC g513724g28k22.jpg GRAPHIC 58544
4 GRAPHIC g513724g45t95.jpg GRAPHIC 52652
5 GRAPHIC g513724g51b13.jpg GRAPHIC 54206
6 GRAPHIC g513724g52a16.jpg GRAPHIC 52255
7 GRAPHIC g513724g53m31.jpg GRAPHIC 114615
8 GRAPHIC g513724g53s64.jpg GRAPHIC 18131
9 GRAPHIC g513724g66h96.jpg GRAPHIC 45749
10 GRAPHIC g513724g74a66.jpg GRAPHIC 37809
11 GRAPHIC g513724g84t81.jpg GRAPHIC 85415
12 GRAPHIC g513724g89r54.jpg GRAPHIC 33125
  Complete submission text file 0001193125-14-037802.txt   3876740
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-193154 | Film No.: 14577951
SIC: 2834 Pharmaceutical Preparations